Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

2(40.0%)

Phase 3

1(20.0%)

Phase 2

1(20.0%)

N/A

1(20.0%)

5Total

Phase 4(2)

Phase 3(1)

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02008656Phase 2Active Not Recruiting

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Role: collaborator

NCT02186600Phase 3Completed

Heartland Osteoporosis Prevention Study

Role: collaborator

NCT01042561Not ApplicableCompleted

Vitamin D Status and Dose Response in Infants

Role: collaborator

NCT02426164Phase 4Withdrawn

Liposomal Bupivacaine in Total Knee Arthroplasty

Role: collaborator

NCT01873768Phase 4Completed

Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement

Role: collaborator

All 5 trials loaded